PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative articles on the practical application of health economics and outcomes research to optimize healthcare resource allocation. An essential resource for clinicians, those involved in health technology assessment and other professionals involved with healthcare resource allocation, budgeting and prescribing decisions.

PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to all healthcare interventions (drugs, diagnostics, devices, personalized medicine and surgical interventions).

As a hybrid journal, PharmacoEconomics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘Learn about publishing Open Access with us’ link below.

PharmacoEconomics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Journal information

  • Christopher I. Carswell,
  • Timothy Wrightson
Publishing model
Hybrid. Learn about publishing Open Access with us

Journal metrics

4.981 (2020)
Impact factor
5.733 (2020)
Five year impact factor
24 days
Submission to first decision
431,902 (2020)

Latest articles

  1. The EQ-5D-5L Valuation Study in Egypt

    Authors (first, second and last of 6)

    • Sahar Al Shabasy
    • Maggie Abbassi
    • Samar Farid
    • Content type: Original Research Article
    • Open Access
    • Published: 17 November 2021

Journal updates

View all updates

About this journal

Electronic ISSN
Print ISSN
Abstracted and indexed in
  1. ABS Academic Journal Quality Guide
  2. ANVUR
  3. Australian Business Deans Council (ABDC) Journal Quality List
  4. BFI List
  6. CNKI
  8. Current Contents/Clinical Medicine
  9. Dimensions
  10. EBSCO Academic Search
  11. EBSCO Advanced Placement Source
  12. EBSCO Business Source
  14. EBSCO Discovery Service
  15. EBSCO Health Business
  16. EBSCO Health Policy Reference Center
  17. EBSCO STM Source
  18. EMBASE
  19. EMCare
  20. Google Scholar
  21. Japanese Science and Technology Agency (JST)
  22. Journal Citation Reports/Science Edition
  23. Journal Citation Reports/Social Sciences Edition
  24. Medline
  25. Naver
  26. OCLC WorldCat Discovery Service
  27. Portico
  28. ProQuest ABI/INFORM
  29. ProQuest-ExLibris Primo
  30. ProQuest-ExLibris Summon
  31. Reaxys
  32. Research Papers in Economics (RePEc)
  33. SCImago
  34. SCOPUS
  35. Science Citation Index
  36. Science Citation Index Expanded (SciSearch)
  37. Semantic Scholar
  38. Social Science Citation Index
  39. TD Net Discovery Service
  40. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG